399 results on '"Bertini R."'
Search Results
2. How to perform the optimal renal biopsy: A machine learning-based indication
3. The effect of metabolic syndrome on long-term renal function after partial nephrectomy
4. Clinical characteristics of patients with renal cancer do impact more than ischemia time on post-operative renal function
5. Erratum to: Hadron transverse momentum distributions in muon deep inelastic scattering at 160 GeV/c
6. Renal tumor heterogeneity in sporadic and inherited renal cancer: a translational multimodal approach
7. Concordance of renal sinus or calyces invasion between preoperative imaging and final pathology after surgery for kidney cancer
8. Active surveillance for very small renal masses: Analysis from an observational prospective trial (NCT03804320)
9. Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy
10. The learning curve of radical nephrectomy for kidney cancer: implications for surgical training
11. Oncologic outcomes in patients diagnosed with PT3A non-metastatic renal cell cancer according to renal vein thrombus or fat invasion
12. When to de-intensify oncologic surveillance scheme for non-clear cell renal cell carcinoma
13. Frailty status predicts worse postoperative and long-term oncologic outcomes in patients treated with partial nephrectomy for small renal masses
14. Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel Lindau renal cell carcinoma
15. Application of the keynote-564 trial results to real life population: which patients with advanced kidney cancer should receive adjuvant pembrolizumab
16. Imaging intensity after surgery for clear cell renal cell carcinoma
17. Risks and benefits of partial nephrectomy with limited or without ischemia time
18. The added value of histological subtype in the prediction of oncologic outcomes in patients with non-metastatic papillary renal cell carcinoma
19. Surgical treatment for Von Hippel Lindau renal cell carcinoma: analysis of clinical outcomes from the san raffaele VHL program
20. The current role of renal tumor biopsy in small renal masses: long-term results from a prospective, single-institutional database
21. Five-year trend of blood and urine cultures in a tertiary-referral urology center for hospitalized patients: a real-life study
22. Re: Toward Individualized Approaches to Partial Nephrectomy: Assessing the Correlation between Ischemia Time and Patient Health Status (RECORD2 Project)
23. Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project)
24. Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project)
25. Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients
26. The learning curve of radical nephrectomy for kidney cancer: Implications for surgical training
27. Neglected lymph nodal metastases in patients with renal cancer: When to extend the anatomical template of lymph node dissection during nephrectomy
28. Assessing the effect of red blood cell transfusion on the risk of acute kidney injury after nephron-sparing surgery
29. Precision surgery for Von Hippel-Lindau renal cell carcinoma
30. The detrimental effect of frailty status on renal function recovery after partial nephrectomy – long-term results from a prospective surgical cohort
31. Imaging intensity after surgery for clear cell renal cell carcinoma
32. Risks and benefits of partial nephrectomy with limited or without ischemia time
33. The anatomical location of lymphadenopathies at imaging predicts the risk of lymph node invasion at final pathology in patients with renal cell carcinoma
34. The added value of histological subtype in the prediction of oncologic outcomes in patients with non-metastatic papillary renal cell carcinoma
35. Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel-Lindau renal cell carcinoma
36. Clinical outcomes of patients with renal cell carcinoma and imperative indication to become anephric: Implications for multidisciplinary board evaluation
37. Frailty status predicts worse postoperative outcomes and long-term oncologic outcomes in patients treated with partial nephrectomy
38. Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project)
39. Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project)
40. External validation and head-to-head comparison of all the prognostic models recommended by the european association of urology guidelines to predict oncologic outcomes in patients with renal cell carcinoma
41. Preoperative frailty status is a predictor of 90-days readmission in radical cystectomy candidates
42. Is whenever feasible-strategy for partial nephrectomy invariably justified? The impact of tumour clinical size on postoperative renal function
43. Papillary renal cell carcinoma type I and II: Two distinct diseases with different clinical and therapeutical implications
44. Is whenever feasible-strategy for partial nephrectomy invariably justified? The impact of clinical tumour size on postoperative renal function
45. Pre-operative risk calculator of the probability of completing nephron-sparing surgery for kidney cancer: The key role of surgical experience and approach
46. Pathological features and predictors of oncologic outcomes in patients with small renal masses
47. Is whenever feasible-strategy for partial nephrectomy invariably justified? the impact of clinical tumour size on postoperative renal function
48. The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial (NCT03955393)
49. Limited vs extended lymph node dissection in T1G3 bladder cancer patients treated with radical cystectomy: is this group responsible for the negative results of the LEA trial?
50. The importance of sign and symptoms assessment in patients with metastatic renal cell carcinoma: implications for cytoreductive nephrectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.